Profile
Sheng Fu Liao is currently a Director-Supervisory Board at Yue Chang Investment Co. Ltd., Innova Health Care, Inc., and Innova Vision KK.
Previously, he served as a Director-Supervisory Board at Innova Vision Inc. He also worked as a Manager-Finance at Taiwan Mask Corp.
from 1999 to 2018.
Additionally, he was a Member-Supervisory Board at Advagene Biopharma Co., Ltd. from 2016 to 2019.
Mr. Liao is a graduate of National Cheng Kung University.
Sheng Fu Liao active positions
| Companies | Position | Start |
|---|---|---|
Innova Vision KK | Director/Board Member | 16/02/2011 |
Innova Health Care, Inc. | Director/Board Member | 16/02/2011 |
Yue Chang Investment Co. Ltd. /Taiwanmask/ | Director/Board Member | - |
Former positions of Sheng Fu Liao
| Companies | Position | End |
|---|---|---|
| ADVAGENE BIOPHARMA CO., LTD. | Director/Board Member | 22/05/2019 |
| TAIWAN MASK CORPORATION | Director of Finance/CFO | 14/01/2018 |
Innova Vision Inc.
Innova Vision Inc. Medical SpecialtiesHealth Technology Manufactures medical equipment | Director/Board Member | - |
Training of Sheng Fu Liao
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Taiwan Mask Corp.
Taiwan Mask Corp. SemiconductorsElectronic Technology Designs, manufactures and distributes reticles & photomasks | Electronic Technology |
Yue Chang Investment Co. Ltd. /Taiwanmask/ | |
National Cheng Kung University
National Cheng Kung University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innova Vision Inc.
Innova Vision Inc. Medical SpecialtiesHealth Technology Manufactures medical equipment | Health Technology |
Innova Health Care, Inc. | |
Innova Vision KK | |
Advagene Biopharma Co., Ltd.
Advagene Biopharma Co., Ltd. BiotechnologyHealth Technology Engages in the development of products such as nasal influenza vaccine, airway allergy immunotherapy and COVID-19 immunotherapy | Health Technology |
- Stock Market
- Insiders
- Sheng Fu Liao
















